‘E-Cigarette And Vaporizer Market Worth Over $9.5 Billion In 2017’ Says Visiongain Report

21 August 2017
Pharma

Visiongain’s new report The Global E-Cigarette & Vaporizer Market Forecast 2017-2027: Revenue Prospects by Product Type (Disposable, Rechargeable, eGo & Tanks, Personal Vaporisers & Mods and Others) and Geography indicates that the E-Cigarette and Vaporizer market will see over $9.5bn in revenue in 2017.
The lead analyst of the report said:

“The e-cigarette industry has undergone profound transformation and has rapidly evolved into a promising business opportunity during the last decade. The products have progressed into the third generation with the introduction of smart e-cigarettes and continue to evolve into more consumer-friendly devices.

The market for electronic cigarettes is currently in a more viable state in the developed countries of the world, primarily due to a greater awareness of the health hazards of traditional cigarettes. The electronic cigarette industry is directing its efforts at this region, where sales of traditional cigarettes are plummeting. However, developing countries might soon follow the same pattern in the coming years.

This report evaluates the current global market size of the E-Cigarette & Vaporizer market in terms of the current market value and value forecasts to 2027. The objective of report is also to identify the prevailing trends in the E cigarette & vaporizer market and the drivers, restraints, opportunities, and challenges along with new business opportunities in the near future.”

The 197-page report contains 99 tables, charts and graphs that add visual analysis in order to explain developing trends within the E-Cigarette & Vaporizer market. Visiongain provides revenue forecasts for the period 2017-2027 for the world E-Cigarette and Vaporizer market with forecasts at a global, regional and national level for 5 different Product Types (Disposable, Rechargeable, eGo & Tanks, Personal Vaporisers & Mods and Others) – discover the industry’s prospects, finding the most lucrative places for investments and revenues in Asia-Pacific, Europe, North America, US, Canada, Germany, UK, France, Russia, Japan, China, India, South Korea and Australia.

The 197-page report offers market forecasts and analysis for 3 regional and 11 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 9 companies leading the E-Cigarette and Vaporizer field in detail.

The Global E-Cigarette & Vaporizer Market Forecast 2017-2027: Revenue Prospects by Product Type (Disposable, Rechargeable, eGo & Tanks, Personal Vaporisers & Mods and Others) and Geography report will be of value to anyone who wants to better understand the E-Cigarette and Vaporizer market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the E-Cigarette and Vaporizer industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read